Currents status of radiotracers for breast cancer imaging in PET
Radiolabeled molecules have become valuable tools in the diagnosis, monitoring, and treatment of cancer, particularly breast cancer. Through the use of radiotracers, clinicians can target specific tumor cells, assess microenvironments, and identify metastases. These radiopharmaceuticals, based on ra...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332500035X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825199430513459200 |
|---|---|
| author | Chloé Jean Stéphane Roux Abdelilah Aziz Maxence Mocquery-corre Rana Bazzi Yacine Merrouche Stéphane Dedieu Nicolas Etique Dimitri Papathanassiou Jérôme Devy |
| author_facet | Chloé Jean Stéphane Roux Abdelilah Aziz Maxence Mocquery-corre Rana Bazzi Yacine Merrouche Stéphane Dedieu Nicolas Etique Dimitri Papathanassiou Jérôme Devy |
| author_sort | Chloé Jean |
| collection | DOAJ |
| description | Radiolabeled molecules have become valuable tools in the diagnosis, monitoring, and treatment of cancer, particularly breast cancer. Through the use of radiotracers, clinicians can target specific tumor cells, assess microenvironments, and identify metastases. These radiopharmaceuticals, based on radionuclides, enable both imaging and therapeutic applications, leading to personalized cancer treatment. Techniques such as PET, SPECT, and the use of nanoparticles for theranostics are at the forefront of innovation, offering improved precision in both diagnosis and therapy. This review explores the various ways in which radiotracers are leveraged in modern oncology, with a focus on breast cancer, and highlights recent advancements in targeted radionuclide therapy and nanoparticle-based applications. |
| format | Article |
| id | doaj-art-83ac3bc0985d409e8e22a9f7b6c8f512 |
| institution | Kabale University |
| issn | 1936-5233 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Translational Oncology |
| spelling | doaj-art-83ac3bc0985d409e8e22a9f7b6c8f5122025-02-08T05:00:05ZengElsevierTranslational Oncology1936-52332025-03-0153102304Currents status of radiotracers for breast cancer imaging in PETChloé Jean0Stéphane Roux1Abdelilah Aziz2Maxence Mocquery-corre3Rana Bazzi4Yacine Merrouche5Stéphane Dedieu6Nicolas Etique7Dimitri Papathanassiou8Jérôme Devy9Université de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, France; Université de Reims Champagne Ardenne, CRESTIC, Reims, FranceUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), F-25000 Besançon, FranceUniversité de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, FranceUniversité de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, FranceUniversité Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), F-25000 Besançon, FranceInstitut Godinot, Reims, FranceUniversité de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, FranceUniversité de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, FranceInstitut Godinot, Reims, France; Université de Reims Champagne Ardenne, CRESTIC, Reims, FranceUniversité de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, France; Corresponding author.Radiolabeled molecules have become valuable tools in the diagnosis, monitoring, and treatment of cancer, particularly breast cancer. Through the use of radiotracers, clinicians can target specific tumor cells, assess microenvironments, and identify metastases. These radiopharmaceuticals, based on radionuclides, enable both imaging and therapeutic applications, leading to personalized cancer treatment. Techniques such as PET, SPECT, and the use of nanoparticles for theranostics are at the forefront of innovation, offering improved precision in both diagnosis and therapy. This review explores the various ways in which radiotracers are leveraged in modern oncology, with a focus on breast cancer, and highlights recent advancements in targeted radionuclide therapy and nanoparticle-based applications.http://www.sciencedirect.com/science/article/pii/S193652332500035XRadiotracersBreast cancerRadiopharmaceuticalsTargeted radionuclide therapyNanoparticles |
| spellingShingle | Chloé Jean Stéphane Roux Abdelilah Aziz Maxence Mocquery-corre Rana Bazzi Yacine Merrouche Stéphane Dedieu Nicolas Etique Dimitri Papathanassiou Jérôme Devy Currents status of radiotracers for breast cancer imaging in PET Translational Oncology Radiotracers Breast cancer Radiopharmaceuticals Targeted radionuclide therapy Nanoparticles |
| title | Currents status of radiotracers for breast cancer imaging in PET |
| title_full | Currents status of radiotracers for breast cancer imaging in PET |
| title_fullStr | Currents status of radiotracers for breast cancer imaging in PET |
| title_full_unstemmed | Currents status of radiotracers for breast cancer imaging in PET |
| title_short | Currents status of radiotracers for breast cancer imaging in PET |
| title_sort | currents status of radiotracers for breast cancer imaging in pet |
| topic | Radiotracers Breast cancer Radiopharmaceuticals Targeted radionuclide therapy Nanoparticles |
| url | http://www.sciencedirect.com/science/article/pii/S193652332500035X |
| work_keys_str_mv | AT chloejean currentsstatusofradiotracersforbreastcancerimaginginpet AT stephaneroux currentsstatusofradiotracersforbreastcancerimaginginpet AT abdelilahaziz currentsstatusofradiotracersforbreastcancerimaginginpet AT maxencemocquerycorre currentsstatusofradiotracersforbreastcancerimaginginpet AT ranabazzi currentsstatusofradiotracersforbreastcancerimaginginpet AT yacinemerrouche currentsstatusofradiotracersforbreastcancerimaginginpet AT stephanededieu currentsstatusofradiotracersforbreastcancerimaginginpet AT nicolasetique currentsstatusofradiotracersforbreastcancerimaginginpet AT dimitripapathanassiou currentsstatusofradiotracersforbreastcancerimaginginpet AT jeromedevy currentsstatusofradiotracersforbreastcancerimaginginpet |